Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great distress to the patients. In the course of a study conducted at MedUni Wien a research team […]
Read More… from Atopic dermatitis: viruses discovered as new therapy option
New molecular mechanisms identified in chronic skin inflammation:Frequently occurring chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis have different causes such as genetic predisposition, stress or allergens. These frequently occurring skin diseases are mostly attributed by biomedical scientists to a disturbed immune system, although the noticeable thickening and flaking of the […]
Read More… from New molecular mechanisms identified in dermatitis
APOSEC is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna. Together with dermatological basic researcher Michael Mildner, also from MedUni Vienna, he has now also investigated the efficacy of the substance in the treatment of allergic skin lesions such as contact dermatitis, since the anti-inflammatory effects of APOSEC are […]
Read More… from Contact dermatitis: potential new treatments